| Date | Time | Source | Announcement |
|---|---|---|---|
| 20 Feb 2004 | 12:11 PM | Holding(s) in Company | |
| 18 Feb 2004 | 10:28 AM | Holding(s) in Company | |
| 17 Feb 2004 | 11:04 AM | Additional Listing | |
| 16 Feb 2004 | 03:49 PM | Additional Listing | |
| 13 Feb 2004 | 05:07 PM | Holding(s) in Company | |
| 09 Feb 2004 | 05:26 PM | Additional Listing | |
| 05 Feb 2004 | 07:00 AM | Exercising second call option | |
| 19 Jan 2004 | 10:19 AM | Re Agreement | |
| 05 Dec 2003 | 07:00 AM | DTI Grant Awarded | |
| 28 Nov 2003 | 07:00 AM | Announcement of Fundraising | |
| 22 Sep 2003 | 07:00 AM | Interim Results | |
| 15 Sep 2003 | 12:17 PM | Notice of Results | |
| 02 Sep 2003 | 02:28 PM | Holding(s) in Company | |
| 22 Jul 2003 | 08:11 AM | Admission to AIM |
Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
FUM share price listed on AIM in 2003.